• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dyne Therapeutics Inc (NQ: DYN )

    45.00 -1.53 (-3.29%)
    Streaming Delayed Price Updated: 3:27 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Dyne Therapeutics Inc

    < Previous 1 2 3 Next >
    Why Low Volume In S&P 500 Could Be Signaling A Hidden Opportunity?
    Find out the significance of the 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday?
    A wave of bullish sentiment swept through Wall Street on Tuesday after lower-than-expected producer inflation data solidified expectations for Federal Reserve rate cuts, prompting speculators to... 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    DYN Stock Earnings: Dyne Therapeutics Beats EPS for Q2 2024
    DYN stock results show that Dyne Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
    10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit... 
    Via Benzinga
    Recap: Dyne Therapeutics Q4 Earnings
    Via Benzinga
    Chart Of The Day: Dyne Therapeutics - Deeply Discounted
    Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United... 
    Via Talk Markets
    Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
    U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    The 3 Most Undervalued Biotech Stocks to Buy in June 2024
    https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate 
    Via InvestorPlace
    Modine Manufacturing Posts Mixed Q4 Results, Joins Viasat, Lululemon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is Dyne Therapeutics Stock Soaring On Monday?
    Dyne Therapeutics reported promising Phase 1/2 trial data for DYNE-101 in myotonic dystrophy type 1 and DYNE-251 in Duchenne muscular dystrophy. Improvements in splicing correction, myotonia, muscle... 
    Via Benzinga
    Tech Surge Boosts Nasdaq To Record Highs
    The Nasdaq Composite Index is up triple digits and marking new record highs, thanks to rising tech stocks. 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Why Dyne Therapeutics, With A 108% Run This Year, Just Catapulted Again
    Dyne Therapeutics is looking to take on Sarepta Therapeutics in DMD. 
    Via Investor's Business Daily
    Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday! 
    Via InvestorPlace
    DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q1 2024
    DYN stock results show that Dyne Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
    U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
    Via Benzinga
    Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
    Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising treatment for Myotonic dystrophy type 1. With strong management, proven... 
    Via Benzinga
    Chardan Capital Maintains Buy Rating for Dyne Therapeutics: Here's What You Need To Know
    Via Benzinga
    Piper Sandler Maintains Overweight Rating for Dyne Therapeutics: Here's What You Need To Know
    Via Benzinga
    DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q4 2023
    DYN stock results show that Dyne Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
    U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Top 4 Health Care Stocks You May Want To Dump In February
    As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
    Via Benzinga
    7 Speculative Stocks to Double Your Money THIS Year
    Although terribly risky, these stocks to double your money could be enticing if you have some pocket change lying around. 
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    $30M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
    Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades. 
    Via Benzinga
    Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of Applied Therapeutics, Inc. 
    Via Benzinga
    Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
    U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.